BAT Releases glo HYPER PRO in Bosnia and Herzegovina

BAT by 2FIRSTS.ai
Jun.21.2024
BAT Releases glo HYPER PRO in Bosnia and Herzegovina
British American Tobacco (BAT) launched its latest heated tobacco device, glo HYPER PRO, in Bosnia and Herzegovina on June 20th.

According to a report by Bljesak.Info on June 20th, British American Tobacco (BAT) unveiled its latest heated tobacco device, glo HYPER PRO, for the first time in Bosnia and Herzegovina.

 

Previously, glo HYPER PRO had been launched in Croatia, Serbia, Italy, Poland, Japan, and other countries. With the launch of glo HYPER PRO, BAT became the first tobacco company to offer all categories of smokeless products (including e-cigarettes, nicotine pouches, and the current glo HYPER PRO heated tobacco product) in the Bosnian market. The company claims that these are also important steps towards BAT's commitment to creating "A Better Tomorrow™" and realizing its vision of a smoke-free world. The company's strategic goal is to shift smokers from traditional tobacco products to lower-risk alternative products, with the aim of becoming the leading company in the smokeless industry by 2035.

 

Furthermore, BAT emphasized its significant contribution to the economy of Bosnia and Herzegovina. BAT has operations in the country, including corporate offices and iNovina, as well as over 400 iNovina kiosks nationwide. In addition, they directly employ over 1000 people in Bosnia and Herzegovina, providing more job opportunities for locals. In 2023, they contributed 336 million convertible marks (KM) to the national budget of Bosnia and Herzegovina.

 

BAT Bosnia and Herzegovina director Johan Baguca stated that

 

The glo HYPER PRO is not just a device, but a perfect combination of technological innovation and exquisite design. Its aim is to introduce new technologies, such as smart LED screens and the HeatBoost induction heating system... For us, the most important thing is the satisfaction of nearly nine million adult glo users worldwide. We believe that this device will be well-received in Bosnia and Herzegovina and will certainly further enhance our position as the only company in the industry to offer a full range of low-risk smoke-free products in the country.

 

The General Manager of BAT Adriatic Region, Zvonko Kolobara, stated

 

I am proud of the launch of our glo HYPER PRO device, which has fully encompassed the low risk product category in the entire Adriatic region market, including Bosnia and Herzegovina, within our BAT product line. This is crucial for BAT and our future business. The key is that we need to offer as wide a range as possible of lower risk alternative products for our consumers, adult smokers. Over the past three years, BAT has invested over 1.4 billion euros in research and development, commercialization, and scientific studies to support its portfolio of lower risk tobacco and nicotine products. These efforts are crucial, as clear regulatory frameworks are needed to differentiate between tobacco and lower risk products and understand the potential of these alternatives for adult smokers.

 

Currently, the glo HYPER PRO device is now available for purchase at iNovina newsstands and other retail locations in Bosnia and Herzegovina.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23